-
OraSure gets Zika funding
OraSure Technologies will get federal funding to develop a Zika test despite Congress' failure to allocate money to fight the mosquito-borne disease. The south Bethlehem diagnostics company announced Tuesday it had been awarded a contract for up to $16.6 million from the U.S. Department of Health and Human Services.
- Categories
- Health Care
-
Paper-based Test Identifies Bogus and Poor Quality Drugs
Counterfeit and substandard medications are a serious problem in the developing world, potentially harming patients who desperately need medical treatment. Some of these drugs — including the antibiotics ciprofloxacin and ceftriaxone — have been deemed essential by the World Health Organization for the treatment of infections.
- Categories
- Health Care
-
As globe-threatening yellow fever epidemic explodes in Congo, people ask ‘where is the vaccine?’
Here in Kinshasa, they’re using bug spray to repel a pandemic. At first glance, it looks like a bloody ambush on civilians: Dozens in uniform are storming into a bustling marketplace bearing on their shoulders what look like bazookas.
- Categories
- Health Care
- Region
- Sub-Saharan Africa
-
The Price of Zika? About $4 Million Per Child
TO TALK ABOUT Zika virus control is to talk about money. Vaccine development, mosquito abatement, and even the distribution of DEET repellant takes (and currently lacks) major federal dollars. When, last week, the US Department of Health and Human Services declared Zika a public health emergency in Puerto Rico, it was in part a means to a better-funded end.
- Categories
- Health Care
-
U.S. Court Upholds United Nations’ Immunity in Cholera Suit
A United States federal appeals panel has upheld that the United Nations cannot be sued in American courts, dealing a setback in a class-action lawsuit brought on behalf of thousands of cholera victims in Haiti.
- Categories
- Health Care
- Region
- North America
-
One Innovative Company is Helping the Fight Against Dengue
Philab Industries, a pioneer in the healthcare business in the Philippines, is expanding to healthcare science and technology bringing in the most advanced diagnostic tools to the country.
- Categories
- Health Care
- Region
- South Asia
-
The race for a Zika vaccine is intense. But it may be missing the most important players
About a year ago, before the Zika virus grabbed global attention, there were zero vaccines for it in development. Today, according to the World Health Organization, there are 30. Some of the work has been astonishingly quick. Human trials for two experimental vaccines have already begun.
- Categories
- Health Care
-
Tata Trusts and The Global Fund launch ‘The India Health Fund’
Tata Trusts, in association with The Global Fund, launched ‘The India Health Fund (IHF)’, at the Taj Mahal Palace in Mumbai yesterday. The India Health Fund is a pioneering vehicle by Tata Trusts, designed to not only influence philanthropic capital within India, but also serve as a trusted mechanism to generate significant impact in addressing key health challenges in the country – starting with malaria and tuberculosis.
- Categories
- Health Care
- Region
- South Asia
The Best of NextBillion in Your Inbox Each Week!
Subscribe to NB Notes for news, jobs & on-the-ground insights from the world of emerging markets business.
We respect your privacy. Your information is safe and will never be shared.
Don't miss out. Subscribe today.